Revvity Inc. (RVTY)
RVTY trades on NYSE in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$155.08
-0.34% on the day
Market cap
$17.3B
Large cap
Revenue · 2025
$2.9B
+3.7% on 2024
Net income · 2025
$241.2M
8.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RVTY on NYSE |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000031791 |
| SEC industry code | Laboratory Analytical Instruments |
| Incorporated in | MA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.9B |
| Net income | $241.2M |
| Operating income | $356.6M |
| Net margin | 8.4% |
| Operating margin | 12.5% |
| Revenue growth | +3.7% |
| Cash | $919.9M |
| Total assets | $12.2B |
| P/E (computed) | 71.7× |
| P/S (computed) | 6.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2025-02-28 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-04 |
| Latest proxy | DEFA14A | 2026-03-16 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.5% |
| 1 month | +9.1% |
| 3 months | +36.9% |
| Year to date | +58.0% |
| 1 year | +68.0% |
| From 52-week high | -2.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AVTR | Avantor Inc. | $15.55 | +0.39% | $10.5B |
| BIO | Bio-Rad Laboratories Inc. | $363.73 | -0.19% | $9.7B |
| TXG | 10x Genomics Inc. | $71.79 | -4.52% | $9.4B |
| MTD | Mettler-Toledo International Inc. | $1598.03 | +2.24% | $32.0B |
| BRKR | Bruker Corporation | $56.19 | -0.11% | $8.6B |
| WAT | Waters Corporation | $429.17 | -0.68% | $42.2B |
| A | Agilent Technologies Inc. | $171.60 | +0.16% | $48.4B |
| ALMR | Alamar Biosciences Inc. | $23.52 | -2.97% | $1.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier